Schedule 13G ownership disclosure

TRAVERE THERAPEUTICS INC

Security class unavailable · CUSIP: 89422G107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,404,443
Percent of class
6.6700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-019252
Form type
SC 13G/A
Filer
Travere Therapeutics, Inc.
CIK
CIK 1438533
Filed
Feb 10, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub